HHV-5 epitope: A potential vaccine candidate with high antigenicity and large coverage

References

• Abd El-Baky, N., Uversky, V. N., & Redwan, E. M. (2017). Virucidal activity of cell-penetrating peptides of viral origin. Journal of Biomolecular Structure and Dynamics, 36, 1739–1746.
   PubMed Web of Science ®Google Scholar
• Aggarwal, M., Singh, A., Grover, S., Pandey, B., Kumari, A., & Grover, A. (2018). Role of pncA gene mutations W68R and W68G in pyrazinamide resistance. Journal of Cellular Biochemistry, 119(3), 2567–2578.
   PubMed Web of Science ®Google Scholar
• Anusuya, S., & Gromiha, M. M. (2017). Quercetin derivatives as non-nucleoside inhibitors for dengue polymerase: Molecular docking, molecular dynamics simulation, and binding free energy calculation. Journal of Biomolecular Structure and Dynamics, 35(13), 2895–2909. doi: 10.1080/07391102.2016.1234416.
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J., van der Spoel, D., & van Drunen, R. (1995). GROMACS: A message-passing parallel molecular dynamics implementation. Computer Physics Communications, 91(1-3), 43–56.
   Web of Science ®Google Scholar
• Bijker, M. S., Melief, C. J., Offringa, R., & Van Der Burg, S. H. (2007). Design and development of synthetic peptide vaccines: past, present and future. Expert review of vaccines, 6(4), 591–603.
   Google Scholar
• Blom, N., Gammeltoft, S., & Brunak, S. (1999). Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. Journal of Molecular Biology, 294(5), 1351–1362.
   PubMed Web of Science ®Google Scholar
• Brusic, V., & Petrovsky, N. (2005). Immunoinformatics and its relevance to understanding human immune disease. Expert Review of Clinical Immunology, 1(1), 145–157.
   PubMedGoogle Scholar
• Bui, H.-H., Sidney, J., Dinh, K., Southwood, S., Newman, M. J., & Sette, A. (2006). Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics, 7, 153.
   PubMed Web of Science ®Google Scholar
• Chakravarti, A., Kashyap, B., & Matlani, M. (2009). Cytomegalovirus infection: An Indian perspective. Indian Journal of Medical Microbiology, 27(1), 3.
   PubMed Web of Science ®Google Scholar
• Colovos, C., & Yeates, T. O. (1993). Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Science, 2(9), 1511–1519.
   PubMed Web of Science ®Google Scholar
• Compton, T. (2004). Receptors and immune sensors: The complex entry path of human cytomegalovirus. Trends in Cell Biology, 14(1), 5–8.
   PubMed Web of Science ®Google Scholar
• Compton, T., Kurt-Jones, E. A., Boehme, K. W., Belko, J., Latz, E., Golenbock, D. T., & Finberg, R. W. (2003). Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. Journal of Virology, 77(8), 4588–4596.
   PubMed Web of Science ®Google Scholar
• Compton, T., Nowlin, D. M., & Cooper, N. R. (1993). Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology, 193(2), 834–841.
   PubMed Web of Science ®Google Scholar
• Demmler, G. J. (1991). Infectious Diseases Society of America and Centers for Disease Control: Summary of a workshop on surveillance for congenital cytomegalovirus disease. Review of Infectious Diseases, 13(2), 315–329.
   PubMedGoogle Scholar
• Doytchinova, I. A., & Flower, D. R. (2007). VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics, 8(1), 4.
   PubMed Web of Science ®Google Scholar
• Feire, A. L., Koss, H., & Compton, T. (2004). Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proceedings of the National Academy of Sciences of the United States of America, 101(43), 15470–15475.
   PubMed Web of Science ®Google Scholar
• Gandhoke, I., Aggarwal, R., Lal, S., & Khare, S. (2006). Congenital CMV infection in symptomatic infants in Delhi and surrounding areas. Indian Journal of Pediatrics, 73(12), 1095–1097.
   PubMedGoogle Scholar
• Gasteiger, E., Hoogland, C., Gattiker, A., Duvaud, S. E., Wilkins, M. R., Appel, R. D., & Bairoch, A. (2005). Protein identification and analysis tools on the ExPASy server. Berlin-Heidelberg-New York: Springer-Verlag.
   Google Scholar
• Guex, N., & Peitsch, M. C. (1997). SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling. Electrophoresis, 18(15), 2714–2723.
   PubMed Web of Science ®Google Scholar
• Ibanez, C. E., Schrier, R., Ghazal, P., Wiley, C., & Nelson, J. A. (1991). Human cytomegalovirus productively infects primary differentiated macrophages. Journal of Virology, 65(12), 6581–6588.
   PubMed Web of Science ®Google Scholar
• Isaacson, M. K., & Compton, T. (2009). Human cytomegalovirus glycoprotein B is required for virus entry and cell-to-cell spread but not for virion attachment, assembly, or egress. Journal of Virology, 83(8), 3891–3903.
   PubMed Web of Science ®Google Scholar
• Kawai, T., & Akira, S. (2005). Pathogen recognition with Toll-like receptors. Current Opinion in Immunology, 17(4), 338–344.
   PubMed Web of Science ®Google Scholar
• Klemin, S. (2008). Molecular biology of the cell, molecular biology of the cell: The problems book. Yale Journal of Biology and Medicine, 81(3), 157.
   Google Scholar
• Kumar, A., Cocco, E., Atzori, L., Marrosu, M. G., & Pieroni, E. (2013). Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: A molecular dynamics simulation study. PloS One, 8(3), e59711.
   PubMed Web of Science ®Google Scholar
• Lazzarotto, T., Guerra, B., Spezzacatena, P., Varani, S., Gabrielli, L., Pradelli, P., … Landini, M. (1998). Prenatal diagnosis of congenital cytomegalovirus infection. Journal of Clinical Microbiology, 36(12), 3540–3544.
   PubMed Web of Science ®Google Scholar
• Lin, S. Y.-H., Cheng, C.-W., & Su, E. C.-Y. (2013). Prediction of B-cell epitopes using evolutionary information and propensity scales. BMC bioinformatics, 14(Suppl 2), S10.
   Google Scholar
• Lindahl, E., Hess, B., & Van Der Spoel, D. (2001). GROMACS 3.0: A package for molecular simulation and trajectory analysis. Journal of Molecular Modeling, 7(8), 306–317.
   Web of Science ®Google Scholar
• Lovell, S. C., Davis, I. W., Arendall, W. B., de Bakker, P. I., Word, J. M., Prisant, M. G., … Richardson, D. C. (2003). Structure validation by Cα geometry: Φ, ψ and Cβ deviation. Proteins: Structure, Function, and Bioinformatics, 50(3), 437–450.
   PubMed Web of Science ®Google Scholar
• Macindoe, G., Mavridis, L., Venkatraman, V., Devignes, M.-D., & Ritchie, D. W. (2010). HexServer: An FFT-based protein docking server powered by graphics processors. Nucleic Acids Research, 38, W445–W449.
   PubMed Web of Science ®Google Scholar
• Moutsopoulos, N., Routsias, J., Vlachoyiannopoulos, P., Tzioufas, A., & Moutsopoulos, H. (2000). B-cell epitopes of intracellular autoantigens: Myth and reality. Molecular Medicine, 6(3), 141–151.
   PubMed Web of Science ®Google Scholar
• Nagpal, N., Goyal, S., Wahi, D., Jain, R., Jamal, S., Singh, A., … Grover, A. (2015). Molecular principles behind Boceprevir resistance due to mutations in hepatitis C NS3/4A protease. Gene, 570(1), 115–121.
   PubMed Web of Science ®Google Scholar
• NCBI. (2016). Database resources of the National Center for Biotechnology Information. Nucleic Acids Research, 44(D1), D7.
   PubMed Web of Science ®Google Scholar
• Omer, A., & Singh, P. (2017). An integrated approach of network-based systems biology, molecular docking, and molecular dynamics approach to unravel the role of existing antiviral molecules against AIDS-associated cancer. Journal of Biomolecular Structure and Dynamics, 35(7), 1547–1558.
   PubMed Web of Science ®Google Scholar
• Pandey, B., Grover, S., Tyagi, C., Goyal, S., Jamal, S., Singh, A., … Grover, A. (2017). Double mutants in DNA gyrase lead to ofloxacin resistance in Mycobacterium tuberculosis. Journal of Cellular Biochemistry, 118(9), 2950–2957.
   PubMed Web of Science ®Google Scholar
• Pass, R. F., Zhang, C., Evans, A., Simpson, T., Andrews, W., Huang, M.-L., … Flanigan, C. (2009). Vaccine prevention of maternal cytomegalovirus infection. New England Journal of Medicine, 360(12), 1191–1199.
   PubMed Web of Science ®Google Scholar
• Patel, K., Tyagi, C., Goyal, S., Jamal, S., Wahi, D., Jain, R., … Grover, A. (2015). Identification of chebulinic acid as potent natural inhibitor of M. tuberculosis DNA gyrase and molecular insights into its binding mode of action. Computational Biology and Chemistry, 59, 37–47.
   PubMed Web of Science ®Google Scholar
• Phillips, S. L., & Bresnahan, W. A. (2011). Identification of binary interactions between human cytomegalovirus virion proteins. Journal of Virology, 85(1), 440–447.
   PubMed Web of Science ®Google Scholar
• Reche, P. A., Glutting, J.-P., & Reinherz, E. L. (2002). Prediction of MHC class I binding peptides using profile motifs. Human Immunology, 63(9), 701–709.
   PubMed Web of Science ®Google Scholar
• Ryan, K. J., & Ray, C. G. (2004). Medical microbiology. New York, NY: McGraw Hill.
   Google Scholar
• Saha, S., & Raghava, G. (2006). Prediction of continuous B‐cell epitopes in an antigen using recurrent neural network. Proteins: Structure, Function, and Bioinformatics, 65(1), 40–48.
   PubMed Web of Science ®Google Scholar
• Schirle, M., Weinschenk, T., & Stevanović, S. (2001). Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens. Journal of Immunological Methods, 257(1), 1–16.
   PubMed Web of Science ®Google Scholar
• Schreiner, W., Karch, R., Knapp, B., & Ilieva, N. (2012). Relaxation estimation of RMSD in molecular dynamics immunosimulations. Computational and Mathematical Methods in Medicine, 2012, 173521.
   PubMed Web of Science ®Google Scholar
• Singh, A., Goyal, S., Jamal, S., Subramani, B., Das, M., Admane, N., & Grover, A. (2016). Computational identification of novel piperidine derivatives as potential HDM2 inhibitors designed by fragment-based QSAR, molecular docking and molecular dynamics simulations. Structural Chemistry, 27(3), 993–1003.
   Web of Science ®Google Scholar
• Singh, A., Grover, S., Sinha, S., Das, M., Somvanshi, P., & Grover, A. (2017). Mechanistic principles behind molecular mechanism of Rifampicin resistance in mutant RNA polymerase beta subunit of Mycobacterium tuberculosis. Journal of Cellular Biochemistry, 118(12), 4594–4606.
   PubMed Web of Science ®Google Scholar
• Singh, A., Singh, A., Grover, S., Pandey, B., Kumari, A., & Grover, A. (2018). Wild-type catalase peroxidase vs G279D mutant type: Molecular basis of Isoniazid drug resistance in Mycobacterium tuberculosis. Gene, 641, 226–234.
   PubMed Web of Science ®Google Scholar
• Singh, H., & Raghava, G. (2001). ProPred: Prediction of HLA-DR binding sites. Bioinformatics, 17(12), 1236–1237.
   PubMed Web of Science ®Google Scholar
• Sinzger, C., Kahl, M., Laib, K., Klingel, K., Rieger, P., Plachter, B., & Jahn, G. (2000). Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus. Journal of General Virology, 81(12), 3021–3035.
   PubMedGoogle Scholar
• Thévenet, P., Shen, Y., Maupetit, J., Guyon, F., Derreumaux, P., & Tufféry, P. (2012). PEP-FOLD: An updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides. Nucleic Acids Research, 40(W1), W288–W293.
   PubMed Web of Science ®Google Scholar
• Verma, S., Grover, S., Tyagi, C., Goyal, S., Jamal, S., Singh, A., & Grover, A. (2016). Hydrophobic interactions are a key to MDM2 inhibition by polyphenols as revealed by molecular dynamics simulations and MM/PBSA free energy calculations. PloS One, 11(2), e0149014.
   PubMed Web of Science ®Google Scholar
• Verma, S., Singh, A., Kumari, A., Goyal, S., Jamal, S., Sinha, S., & Grover, A. (2017a). Dissecting the role of mutations in chymase inhibition: Free energy and decomposition analysis. Gene, 609, 68–79.
   PubMed Web of Science ®Google Scholar
• Verma, S., Singh, A., Kumari, A., Tyagi, C., Goyal, S., Jamal, S., & Grover, A. (2017b). Natural polyphenolic inhibitors against the antiapoptotic BCL-2. Journal of Receptors and Signal Transduction, 37(4), 391–400.
   PubMed Web of Science ®Google Scholar
• Vora, J., Patel, S., Sinha, S., Sharma, S., Srivastava, A., Chhabria, M., & Shrivastava, N. (2018). Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV. Journal of Biomolecular Structure and Dynamics 35, 2631–2644.
   Google Scholar
• Wang, X., Huong, S.-M., Chiu, M. L., Raab-Traub, N., & Huang, E.-S. (2003). Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature, 424(6947), 456–461.
   PubMed Web of Science ®Google Scholar
• Wiederstein, M., & Sippl, M. J. (2007). ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Research, 35(Suppl 2), W407–W410.
   PubMed Web of Science ®Google Scholar
• Xiao, Y., Lu, Y., & Chen, Y.-H. (2001). Epitope-vaccine as a new strategy against HIV-1 mutation. Immunology Letters, 77(1), 3–6.
   PubMed Web of Science ®Google Scholar